Karen Akinsanya - 09 Feb 2023 Form 4 Insider Report for Schrodinger, Inc. (SDGR)

Role
President of R&D, Therapeutics
Signature
/s/ Donald Shum, as attorney-in-fact for Karen Akinsanya
Issuer symbol
SDGR
Transactions as of
09 Feb 2023
Net transactions value
$0
Form type
4
Filing time
10 Feb 2023, 15:59:58 UTC
Previous filing
16 Jun 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SDGR Stock Option (right to buy) Award $0 +63,270 $0.000000 63,270 09 Feb 2023 Common Stock 63,270 $23.29 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on February 9, 2023. The shares underlying the option are scheduled to vest with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.